Infinity Financial Statements From 2010 to 2022

INFI
 Stock
  

USD 1.15  0.12  9.45%   

Infinity Pharmaceuti financial statements provide useful quarterly and yearly information to potential Infinity Pharmaceuti investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Infinity Pharmaceuti financial statements helps investors assess Infinity Pharmaceuti's valuation, profitability, and current liquidity needs.
We have found ninety-seven available fundamental trends for Infinity Pharmaceuti, which can be analyzed and compared to other ratios and to its competitors. Please verify all of Infinity Pharmaceuti regular fundamental drivers against the trend between 2010 and 2022 to make sure the company can sustain itself down the road.
Infinity Pharmaceuti Average Equity is most likely to decrease significantly in the upcoming years. The last year's value of Average Equity was reported at 36.83 Million. The current Enterprise Value is estimated to increase to about 114.2 M, while Net Income Per Employee is projected to decrease to (1.5 M).
  
Check Infinity Pharmaceuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Infinity main balance sheet or income statement drivers, such as Gross Profit of 1.9 M, Interest Expense of 184.7 K or Operating Expenses of 64.1 M, as well as many exotic indicators such as Long Term Debt to Equity of 0.27, PPandE Turnover of 1.29 or Receivables Turnover of 761. Infinity financial statements analysis is a perfect complement when working with Infinity Pharmaceuti Valuation or Volatility modules. It can also supplement Infinity Pharmaceuti's financial leverage analysis and stock options assessment as well as various Infinity Pharmaceuti Technical models . Please see the analysis of Infinity Pharmaceuti Correlation against competitors.

Infinity Pharmaceuti Revenues

1.91 Million

Infinity Pharmaceuti Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets112.3 M84.8 M154.1 M
Decreasing
Slightly volatile
Cash and Equivalents83 M80.7 M89.8 M
Decreasing
Stable
Investments162.2 K158 K49.5 M
Decreasing
Slightly volatile
Investments Current5.1 MM49.8 M
Decreasing
Slightly volatile
Investments Non Current162.2 K158 K513.6 K
Decreasing
Slightly volatile
Deferred Revenue169 K164.7 K43.8 M
Decreasing
Slightly volatile
Property Plant and Equipment Net2.4 M2.3 M7.7 M
Decreasing
Stable
Trade and Non Trade Receivables2.1 M2.1 M1.9 M
Increasing
Stable
Trade and Non Trade Payables2.4 M2.3 M6.3 M
Decreasing
Slightly volatile
Total Liabilities61.7 M63.2 M70.3 M
Decreasing
Stable
Shareholders Equity22.1 M21.6 M81.7 M
Decreasing
Slightly volatile
Accumulated Other Comprehensive Income(924)(900)36.9 K
Decreasing
Slightly volatile
Current Assets106.6 M82.3 M144.6 M
Decreasing
Slightly volatile
Assets Non Current2.6 M2.5 M9.4 M
Decreasing
Stable
Current Liabilities17.4 M13.3 M24.5 M
Decreasing
Slightly volatile
Liabilities Non Current44.3 M49.9 M45.8 M
Decreasing
Stable
Total Debt941.1 K917 K14.5 M
Decreasing
Slightly volatile
Debt Current7.4 M6.9 M3.2 M
Increasing
Slightly volatile
Debt Non Current941.1 K917 K14 M
Decreasing
Slightly volatile
Shareholders Equity USD22.1 M21.6 M81.7 M
Decreasing
Slightly volatile
Cash and Equivalents USD83 M80.7 M89.8 M
Decreasing
Stable
Total Debt USD941.1 K917 K14.5 M
Decreasing
Slightly volatile
Accounts Payable3.3 M2.3 M3.6 M
Decreasing
Slightly volatile
Receivables856.7 K1.1 MM
Increasing
Slightly volatile

Infinity Pharmaceuti Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues1.9 M1.9 M55.9 M
Decreasing
Slightly volatile
Selling General and Administrative Expense17.6 M14.2 M23.4 M
Decreasing
Slightly volatile
Research and Development Expense32.5 M31.6 M81.3 M
Decreasing
Slightly volatile
Operating Expenses64.1 M46.9 M94.3 M
Decreasing
Slightly volatile
Interest Expense184.7 K180 K2.6 M
Decreasing
Slightly volatile
Income Tax Expense(52.4 K)(48.6 K)(34.8 K)
Decreasing
Slightly volatile
Weighted Average Shares74.6 M85.6 M51 M
Increasing
Slightly volatile
Weighted Average Shares Diluted74.6 M85.6 M51 M
Increasing
Slightly volatile
Revenues USD1.9 M1.9 M55.9 M
Decreasing
Slightly volatile
Gross Profit1.9 M1.9 M55.9 M
Decreasing
Slightly volatile

Infinity Pharmaceuti Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Capital Expenditure(11.9 K)(11 K)(1.3 M)
Increasing
Stable
Net Cash Flow Investment Acquisitions and Disposals6.8 M5.5 M5.3 M
Increasing
Stable
Net Cash Flow from Financing94 M87.1 M49.9 M
Decreasing
Stable
Issuance Repayment of Debt Securities (3.7 M)(3.6 M)6.1 M
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares94 M87.1 M39 M
Decreasing
Very volatile
Net Cash Flow from Investing6.1 M5.5 M4.2 M
Increasing
Stable
Net Cash Flow from Operations(43.8 M)(40.6 M)(44.9 M)
Increasing
Very volatile
Net Cash Flow or Change in Cash and Cash Equivalents56.1 M52 M9.1 M
Decreasing
Very volatile
Share Based Compensation2.8 M2.7 MM
Decreasing
Slightly volatile
Depreciation Amortization and Accretion492.6 K480 K1.4 M
Decreasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Return on Average Equity(1.26)(1.229)(0.5547)
Increasing
Stable
Return on Invested Capital9.08.340.382
Increasing
Slightly volatile
Gross Margin0.890.90.9842
Decreasing
Slightly volatile
Asset Turnover0.01950.0190.3212
Decreasing
Slightly volatile
Enterprise Value over EBITDA(2.69)(2.494)(11.1451)
Increasing
Stable
Sales per Share0.02260.0221.4229
Decreasing
Slightly volatile
Price to Sales Ratio11210428.6925
Increasing
Slightly volatile
Price to Book Value10.029.2855.453
Decreasing
Slightly volatile
Debt to Equity Ratio3.162.9312.0536
Decreasing
Stable
Current Ratio6.056.1866.3837
Decreasing
Stable
Free Cash Flow per Share(0.51)(0.475)(1.0199)
Increasing
Stable
Book Value per Share0.260.2521.9445
Decreasing
Slightly volatile
Tangible Assets Book Value per Share1.020.9913.5813
Decreasing
Slightly volatile
Total Assets Per Share0.970.9513.2872
Decreasing
Slightly volatile
Cash Flow Per Share(0.49)(0.4556)(0.8985)
Increasing
Stable
Receivables Turnover761765837
Decreasing
Slightly volatile
PPandE Turnover1.291.259220.2429
Increasing
Very volatile
Cash and Equivalents Turnover0.03490.0340.9016
Decreasing
Slightly volatile
Accounts Payable Turnover0.720.700913.4194
Decreasing
Slightly volatile
Accrued Expenses Turnover0.240.22813.7528
Decreasing
Slightly volatile
Long Term Debt to Equity0.270.270.5666
Decreasing
Slightly volatile
Quick Ratio5.94.91865.741
Decreasing
Stable
Net Current Assets as percentage of Total Assets86.1581.344675.7237
Increasing
Stable
Revenue to Assets0.02250.02190.2691
Decreasing
Slightly volatile

Infinity Pharmaceuti Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Capitalization263.1 M200.3 M355.3 M
Decreasing
Slightly volatile
Enterprise Value114.2 M111.3 M277.3 M
Decreasing
Slightly volatile
Invested Capital(8.5 M)(8.3 M)47.9 M
Decreasing
Slightly volatile
Average Equity55.8 M36.8 M80 M
Decreasing
Slightly volatile
Average Assets115.5 M98.6 M145.2 M
Decreasing
Slightly volatile
Invested Capital Average(5.5 M)(5.4 M)51.5 M
Decreasing
Slightly volatile
Tangible Asset Value112.3 M84.8 M154.1 M
Decreasing
Slightly volatile
Free Cash Flow(43.8 M)(40.6 M)(46 M)
Increasing
Very volatile
Working Capital89.2 M69 M120.1 M
Decreasing
Slightly volatile
Revenue Per Employee57.8 K56.3 K437.1 K
Decreasing
Slightly volatile

Infinity Fundamental Market Drivers

Forward Price Earnings-1.59
Short Percent Of Float1.60%
Average Daily Volume Last 10 Day606.35k
Shares Short Prior Month1.59M
Average Daily Volume In Three Month687.97k
Date Short Interest29th of July 2022
Fifty Day Average0.7106
Two Hundred Day Average1.2849

Infinity Upcoming Events

Upcoming Quarterly Report15th of March 2022
Next Financial Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End15th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Infinity Pharmaceuti Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Infinity Pharmaceuti income statement, its balance sheet, and the statement of cash flows. Infinity Pharmaceuti investors use historical funamental indicators, such as Infinity Pharmaceuti's revenue or net income, to determine how well the company is positioned to perform in the future. Although Infinity Pharmaceuti investors may use each financial statement separately, they are all related. The changes in Infinity Pharmaceuti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Infinity Pharmaceuti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Infinity Pharmaceuti Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Infinity Pharmaceuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Deferred Revenue164.7 K169 K
Revenues1.9 M1.9 M
Revenue to Assets 0.021914  0.0225 
Revenue Per Employee56.3 K57.8 K
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.

Infinity Pharmaceuti Investors Sentiment

The influence of Infinity Pharmaceuti's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Infinity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Infinity Pharmaceuti Implied Volatility

    
  162.39  
Infinity Pharmaceuti's implied volatility exposes the market's sentiment of Infinity Pharmaceuti stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Infinity Pharmaceuti's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Infinity Pharmaceuti stock will not fluctuate a lot when Infinity Pharmaceuti's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Infinity Pharmaceuti in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Infinity Pharmaceuti's short interest history, or implied volatility extrapolated from Infinity Pharmaceuti options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see the analysis of Infinity Pharmaceuti Correlation against competitors. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
102.7 M
Quarterly Revenue Growth YOY
0.34
Return On Assets
-0.35
Return On Equity
-2.31
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.